Schnitzer TJ, et al. Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or Knee. ACR 2018, abstract L20.
Vivian Weerdesteyn benoemd tot hoogleraar in Nijmegen
apr 2021 | Bewegingsstoornissen, Neuro-vasculair